Stephen G. Kaler

Quick facts

Phase 2 pipeline

• Droxidopa Oral Product · Neurology
  Noradrenergic neuron stimulation

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Stephen G. Kaler portfolio CI brief
• Stephen G. Kaler pipeline updates RSS